227 related articles for article (PubMed ID: 3783201)
1. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.
Kantarjian HM; Keating MJ; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
J Clin Oncol; 1986 Dec; 4(12):1748-57. PubMed ID: 3783201
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
3. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Laughlin MJ; McGaughey DS; Crews JR; Chao NJ; Rizzieri D; Ross M; Gockerman J; Cirrincione C; Berry D; Mills L; Defusco P; LeGrand S; Peters WP; Vredenburgh JJ
J Clin Oncol; 1998 Mar; 16(3):1008-12. PubMed ID: 9508184
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
Le Beau MM; Albain KS; Larson RA; Vardiman JW; Davis EM; Blough RR; Golomb HM; Rowley JD
J Clin Oncol; 1986 Mar; 4(3):325-45. PubMed ID: 3950675
[TBL] [Abstract][Full Text] [Related]
7. Secondary myelodysplastic syndromes and leukaemias.
Levine EG; Bloomfield CD
Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
[TBL] [Abstract][Full Text] [Related]
8. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
Levine EG; Bloomfield CD
Semin Oncol; 1992 Feb; 19(1):47-84. PubMed ID: 1736370
[TBL] [Abstract][Full Text] [Related]
9. Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.
Kantarjian HM; O'Brien S; Shan J; Aribi A; Garcia-Manero G; Jabbour E; Ravandi F; Cortes J; Davisson J; Issa JP
Cancer; 2007 Jan; 109(2):265-73. PubMed ID: 17133405
[TBL] [Abstract][Full Text] [Related]
10. Chromosome study of 85 patients with myelodysplastic syndrome.
Musilova J; Michalova K
Cancer Genet Cytogenet; 1988 Jul; 33(1):39-50. PubMed ID: 3164239
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).
de Witte T; Suciu S; Peetermans M; Fenaux P; Strijckmans P; Hayat M; Jaksic B; Selleslag D; Zittoun R; Dardenne M
Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
13. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
14. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
15. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related leukemia and myelodysplasia in small-cell lung cancer. Report of a case and results of morphologic, cytogenetic, and bone marrow culture studies in long-term survivors.
Dang SP; Liberman BA; Shepherd FA; Messner H; Tweeddale M; Gardner HA; Colgan T; Rose TH; Evans WK
Arch Intern Med; 1986 Sep; 146(9):1689-94. PubMed ID: 3019264
[TBL] [Abstract][Full Text] [Related]
18. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL
Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]